Navigation Links
Pharmacopeia Announces Third Quarter 2007 Financial Results
Date:11/1/2007

322

Operating loss (12,766) (5,122) (30,292) (20,657)

Interest and other income 1,142 419 2,780 1,033

Interest and other expense (15) - (20) -

Change in warrant liability (57) - (1,125) -

Restructuring credits - - - 88

Loss before income taxes (11,696) (4,703) (28,657) (19,536)

(Benefit from) provision

for income taxes - 9 (52) 37

Net loss $(11,696) $(4,712) $(28,605) $(19,573)

Net loss per share:

- Basic and diluted $(0.40) $(0.31) $(1.07) $(1.28)

Weighted average number of

common stock shares

outstanding:

- Basic and diluted 29,566,714 15,297,476 26,737,034 15,244,905

PHARMACOPEIA, INC.

SELECTED FINANCIAL DATA

(Dollars in thousands)

Consolidated Balance Sheets

September 30, December 31,

2007 2006

(unaudited)

Cash, cash equivalents and marketable

securities $81,355 $46,140

Accounts receivable, net 1,013 5,006

Other assets, net 16,828 14,981

Total assets $99,196 $66,127

Current liabilities $29,871 $18,750

Long-term liabilities 27,715 16,946

Total stockholders' equity 41,610 30,431

Total liabilities and stockholders'

equity
'/>"/>

SOURCE Pharmacopeia
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Pharmacopeia Announces Positive Results from Initial DARA Clinical Trial
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Sygnis Pharma AG announces date for presentation of clinical results
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
7. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
8. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2008)..., Dec. 1 TargeGen has announced th...rom a multi-center, US-based clinical,trial of TG...been scheduled at,the 2008 American Society of He...presentation are as follows:, Title: ...ailable, JAK2-Selective In...
(Date:12/1/2008)...study shows the Prox1 gene is a two-way switch tha...ls to be reprogrammed so that they lose their iden..., , MEMPHIS, Tenn., Dec. 1 /PRNewswire-USNe...arch Hospital have discovered that a certain diffe...tity that it requires the constant expression of a...
(Date:12/1/2008)...ence Call Scheduled for Tuesday, December 9 at 11:...- , , SOUTH SAN FRANCISCO, Calif., Dec. 1 ...s, Inc. (Nasdaq: SNSS ), a biopharmaceutical com...ion of new oncology therapeutics, today announced ...eloid leukemia (AML) will be presented during the ...
(Date:11/30/2008)...Dec. 1 Abnormalities in... in children with autism spectrum disorder by usin...dy presented today at the annual meeting of the Ra..., "Using MEG, we can record the tiny magnetic f...said Timothy Roberts, Ph.D., vice chair of researc...
Breaking Medicine Technology:Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 2Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 3Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 2Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 3Brain Waves Show Sound Processing Abnormalities in Autistic Children 2Brain Waves Show Sound Processing Abnormalities in Autistic Children 3Northwest Secures US 241 0 Million Debt Financing 8035 1Northwest Secures US 241 0 Million Debt Financing 8035 2Northwest Secures US 241 0 Million Debt Financing 8035 3Northwest Secures US 241 0 Million Debt Financing 8035 4TorreyPines Therapeutics Reports Successful End of Phase II Meeting With FDA for Tezampanel 8033 1TorreyPines Therapeutics Reports Successful End of Phase II Meeting With FDA for Tezampanel 8033 2TorreyPines Therapeutics Reports Successful End of Phase II Meeting With FDA for Tezampanel 8033 3TorreyPines Therapeutics Reports Successful End of Phase II Meeting With FDA for Tezampanel 8033 4Invest in Kids Rally to Be Held Before St Louis Vice Presidential Debate 26966 1Invest in Kids Rally to Be Held Before St Louis Vice Presidential Debate 26966 2Maryland Stem Cell Commission Issues Requests for Applications 26961 1Maryland Stem Cell Commission Issues Requests for Applications 26961 2Maryland Stem Cell Commission Issues Requests for Applications 26961 3
(Date:12/1/2008)...tute,s cancer registry has found that as many as o...plete radiation treatment following breast-conserv...d to worse outcomes. , Dr. Heather Taffet Gold o...nd that among a nationally representative sample o...d 65 and older, almost 1,300 women experienced del...
(Date:12/1/2008)...ssMutual Retirement Services Division has added tw...fit business. Nonprofit activity has more than tri...n Darby joined MassMutual on December 1 as nonprof...ports to M. Palmer Whitney, national managing dire...t Services Division, who will continue to cover th...
(Date:12/1/2008)...- Senetek PLC,(OTC Bulletin Board: SNKTY), a life...echnologies that target the science of healthy agi...alists in the fields of strategic,development, co...n Zurich,Bern and Geneva has published a Researc...ort, available in the "Investors" section of the C...
(Date:12/1/2008)...antar fasciitis, researchers say , , M...ers say they,ve developed a fast, effective, non-i...nown as plantar fasciitis. , Using a combinatio...by ultrasound, the researchers say their approach ...ondition that afflicts about one million Americans...
Breaking Medicine News(10 mins):Health News:Delays in radiation therapy lead to increased breast cancer recurrence 2Health News:MassMutual Retirement Services Adds Two to Nonprofit Sales Team 2Health News:MassMutual Retirement Services Adds Two to Nonprofit Sales Team 3Health News:New Twist on Treatment of Foot Pain 2Health News:New Twist on Treatment of Foot Pain 3
...ffected states, Tamil Nadu has managed to keep the...que support programme// . The Tamilnadu Aids Init... become a model for other states to emulate. The B...ation's Avahan scheme funds it. Since the HIV vir...
...hing has your full attention you see it vividly. A...miss something important//. Now a new Northwestern...rates. The mystery of how attention improves the p...tion has been a long-time concern of scientists. O...
...ave used a new technique to rapidly detect and pre...oli, without time-consuming// treatments usually r...pray ionization, or DESI, could be used to create ...rs for applications ranging from food safety to ho...
...Niro fears he is going cross-eyed even though his ...ht//. De Niro is now thinking of taking up wearin.... He said: "The optician says there's nothing wro... look in the mirror sometimes. My friend bought me...
Other Medicine News:Health News:Tamil Nadu Checks AIDS Spread 2Health News:Tamil Nadu Checks AIDS Spread 3Health News:Paying Attention Sets Off Symphony of Cell Synchronization 2Health News:New Technique to Identify Bacteria for Food Safety 2Health News:New Technique to Identify Bacteria for Food Safety 3
The generously sized STERILE VIEW Monk Hood from DePuy provides splash protection in the chin and neck areas from body fluids and liquids. Shoulder cut outs and ties ensure a comfortable fit. This pr
...he Nidek NM-200D's compact, lightweight body with ...more options to treat more patients, more comforta... operation and functionality for image capture, pr...ge data to the compact flash card. Through USB int...
PacePath is a comprehensive anatomic pathology software system that is the culmination of more than five years of development and testing by leading industry experts.
...abNet LIS is a Windows NT client server system tha...ity, power and high-speed volume required to meet ...ndustry experts, LabNet is structured to make gene...fective as possible. Our system can upload lab act...
Medicine Products: